Neuroretinal Biomarkers in Neurodegenerative Diseases

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Multiple Sclerosis
Trial Locations (1)

EH16 4SB

Anne Rowling Regenerative Neurology Clinic, Edinburgh

All Listed Sponsors
lead

University of Edinburgh

OTHER

NCT02047760 - Neuroretinal Biomarkers in Neurodegenerative Diseases | Biotech Hunter | Biotech Hunter